Raia Drogasil S.A. RADLY
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.13% | 21.64% | 14.31% | 4.44% | -3.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.13% | 21.64% | 14.31% | 4.44% | -3.69% |
| Cost of Revenue | 20.41% | 19.54% | 13.00% | 3.44% | -4.64% |
| Gross Profit | 29.33% | 26.47% | 17.39% | 6.81% | -1.46% |
| SG&A Expenses | 26.79% | 23.69% | 15.32% | 6.71% | -0.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 935.05% | 956.97% | 1,290.43% | -411.38% | 63.69% |
| Total Operating Expenses | 22.79% | 21.27% | 14.20% | 4.16% | -3.49% |
| Operating Income | 28.51% | 27.43% | 16.15% | 8.71% | -6.71% |
| Income Before Tax | 25.01% | 20.54% | -2.56% | -11.42% | -17.93% |
| Income Tax Expenses | 132.15% | 81.73% | -16.15% | -24.77% | -70.00% |
| Earnings from Continuing Operations | 16.40% | 14.52% | -0.78% | -8.97% | -4.63% |
| Earnings from Discontinued Operations | -87.64% | 45.88% | 658.76% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 184.18% | 150.13% | 74.55% | 76.52% | 44.71% |
| Net Income | 5.40% | 18.51% | 11.83% | 5.82% | 11.04% |
| EBIT | 28.51% | 27.43% | 16.15% | 8.71% | -6.71% |
| EBITDA | 28.82% | 26.93% | 17.90% | 10.36% | -5.18% |
| EPS Basic | 9.07% | 21.88% | 31.11% | 23.03% | 28.36% |
| Normalized Basic EPS | 36.84% | 23.23% | 15.22% | 8.09% | -5.91% |
| EPS Diluted | 8.19% | 20.94% | 30.38% | 22.87% | 28.31% |
| Normalized Diluted EPS | 36.13% | 22.64% | 14.19% | 7.64% | -6.27% |
| Average Basic Shares Outstanding | -3.44% | -2.98% | -17.71% | -17.34% | -16.36% |
| Average Diluted Shares Outstanding | -2.68% | -2.30% | -16.74% | -16.96% | -16.04% |
| Dividend Per Share | -21.46% | -3.37% | 73.10% | 211.45% | -38.79% |
| Payout Ratio | 0.13% | 0.00% | 0.23% | 0.30% | -0.09% |